IBIO (STOCKS)
iBio, Inc. Common Stock
$2.110000
-0.100000 (-4.52%)
Prev close: $2.210000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- CEO
- Martin B. Brenner
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $73.23M
- Employees
- 20
- P/E (TTM)
- -2.10
- P/B (TTM)
- 1.17
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q2)
|
$-0.09 | $-0.08 | -0.0058 | -6.89% |
|
Sep 2025 (Q1)
|
$-0.11 | $-0.10 | -0.0054 | -5.16% |
|
Jun 2025 (Q4)
|
$-0.49 | $-0.37 | -0.1177 | -31.61% |
|
Mar 2025 (Q3)
|
$-0.49 | $-0.33 | -0.1636 | -50.12% |
Financial Statements
| Revenues | $300.00K |
| Benefits Costs and Expenses | $6.26M |
| Costs And Expenses | $25.26M |
| Nonoperating Income/Loss | $736.00K |
| Operating Expenses | $25.77M |
| Research and Development | $12.96M |
| Other Operating Expenses | $12.81M |
| Operating Income/Loss | -$25.47M |
| Income/Loss From Continuing Operations After Tax | -$24.74M |
| Income/Loss From Continuing Operations Before Tax | -$5.96M |
| Income Tax Expense/Benefit | -$8.54M |
| Net Income/Loss | -$24.74M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$24.74M |
| Net Income/Loss Available To Common Stockholders, Basic | -$24.69M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.00 |
| Diluted Earnings Per Share | -$1.00 |
| Basic Average Shares | 163,273,000 |
| Diluted Average Shares | 163,273,000 |
| Assets | $64.39M |
| Current Assets | $53.37M |
| Noncurrent Assets | $11.03M |
| Fixed Assets | $3.45M |
| Intangible Assets | $4.34M |
| Other Non-current Assets | $3.24M |
| Liabilities | $7.83M |
| Current Liabilities | $5.90M |
| Accounts Payable | $2.65M |
| Other Current Liabilities | $3.25M |
| Noncurrent Liabilities | $1.93M |
| Equity | $56.56M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $56.56M |
| Liabilities And Equity | $64.39M |
| Net Cash Flow From Operating Activities | -$18.63M |
| Net Cash Flow From Operating Activities, Continuing | -$18.63M |
| Net Cash Flow From Investing Activities | -$24.45M |
| Net Cash Flow From Investing Activities, Continuing | -$24.45M |
| Net Cash Flow From Financing Activities | $64.73M |
| Net Cash Flow From Financing Activities, Continuing | $64.73M |
| Net Cash Flow | $21.66M |
| Net Cash Flow, Continuing | $21.66M |
| Comprehensive Income/Loss | -$24.73M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$24.71M |
| Other Comprehensive Income/Loss | -$8.97M |